Results 121 to 130 of about 14,468 (231)

The microbial causes of complicated Acute Bacterial Rhinosinusitis and implications for empirical antimicrobial therapy

, 2016
Objectives: Very little up-to-date information is available on the microbiology of complicated acute bacterial rhinosinusitis. Reliable microbiology testing is necessary to inform current empirical antimicrobial treatments.
Sandoe, JAT, Miah, MS, Nix, P, Koukkoullis, A   +3 more
core   +1 more source

Appropriate Medical Therapy Primarily Modifies Type 2 and Severity Biomarkers in Chronic Rhinosinusitis

International Forum of Allergy &Rhinology, Volume 16, Issue 6, Page 595-606, June 2026.
ABSTRACT Background Appropriate medical therapy (AMT) is first‐line treatment for patients with chronic rhinosinusitis (CRS). We evaluated inflammatory structure, treatment‐induced changes, and biomarker‐outcome associations in AMT‐managed patients. Methods Fifty‐one CRS patients were evaluated before and after AMT which included a combination of oral ...
Asher C. Park, Brooke N. Gleason, Eli Stein, Saied Ghadersohi, Atsushi Kato, Stephanie Shintani‐Smith, David B. Conley, Kevin C. Welch, Robert C. Kern, Bruce K. Tan   +9 more
wiley   +1 more source

Rinosinusite acuta recidivante e cronica/ Acute, recurrent and chronic rhinosinusitis.

, 2008
The purpose of this work is to review the modern thinking and treatments useful today regarding Acute and Chronic Rhinosinusitis. The term rhinosinusitis is more pertinent than sinusitis alone since the organ of the nose is the mucosa, and the entire ...
LAURIELLO, MARIA, Kern EB, Bellussi L, Passàli FM, Salerni L, Passàli D, Passàli GC, Damiani V., Galli J   +8 more
core  

Therapeutic potential of safranal in acute bacterial rhinosinusitis: an experimental study

The Egyptian Journal of Otolaryngology
Background Safranal, a pharmacologically active and potent phytochemical, may exhibit significant antioxidant and anti-inflammatory activity in an acute bacterial rhinosinusitis.
Murat Yaşar, Fatma Atalay, Sedat Gökmen, İrfan Çınar, Fatih Öner, Yusuf Aydın, Musa Tatar   +6 more
doaj   +1 more source

Tezepelumab Reduces Alarmin Cytokine Levels in Upper Airway Epithelial Cells in Patients With Severe Asthma

Clinical &Experimental Allergy, EarlyView.
Hazel Marriott, Adil Adatia, Subhabrata Moitra, Paige Lacy   +3 more
wiley   +1 more source

Dupilumab Beyond the Airway: Decreased Morbidity in a Real‐World Analysis

International Forum of Allergy &Rhinology, Volume 16, Issue 6, Page 607-614, June 2026.
ABSTRACT Background Post hoc analyses of clinical trials have characterized dupilumab's adverse effects, yet the real‐world impact in chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma is not well described. This study aims to characterize the risks of lymphoma, cardiovascular events, eosinophilia, joint pain, inflammatory arthritis, and ...
Emma J. Anisman, Spencer Short, Emma Tam, Benjamin F. Bitner, Abdulghafoor Alani, Marc Rosen, Mindy Rabinowitz, Damaris Pena Evertz, Elina Toskala, Gurston G. Nyquist   +9 more
wiley   +1 more source

Revisiting the orbital complications of acute rhinosinusitis. [PDF]

Braz J Otorhinolaryngol, 2023
Anselmo-Lima WT, Soares MR, Fonseca JP, Garcia DM, Velasco E Cruz AA, Tamashiro E, Valera FCP.   +6 more
europepmc   +1 more source

Reproxalap ‐ A Novel Treatment Option for Allergic Conjunctivitis – A Comprehensive Narrative Review

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims Allergic conjunctivitis is a prevalent, immune‐mediated hypersensitivity disorder of the ocular surface affecting 10%–20% of the global population. Current therapeutic options, while effective to some extent, are often limited by side effects and inconsistent efficacy.
Sanila Mughal, Roshanay Ejaz Awan, Hur Abbas, Zahra Sania, Ashna Habib, Syeda Kaneez Sakina, Amina Mahmud, Mohammed Mahmmoud Fadelallah Eljack   +7 more
wiley   +1 more source

Orbital and Intracranial Complications of Acute Rhinosinusitis in a Tertiary Center, Saudi Arabia. [PDF]

Cureus, 2023
Asiri MA, Almusallam MH, Almashari Y, Allarakia Y, Alhedaithy RA.   +4 more
europepmc   +1 more source

Changes in the Epidemiology of Pediatric Olfactory Dysfunction Before and After COVID‐19 Pandemic

Laryngoscope Investigative Otolaryngology, Volume 11, Issue 3, June 2026.
ABSTRACT Background The COVID‐19 pandemic may have altered the epidemiology and clinical features of pediatric olfactory dysfunction, but data focusing on children remain limited, particularly regarding etiological changes and qualitative symptoms such as parosmia.
Yuji Kishimoto, Eri Mori, Rinko Sakurai, Hirotaka Tanaka, Monami Nagai, Rumi Sekine, Masayoshi Tei, Nobuyoshi Otori   +7 more
wiley   +1 more source